2025-06-11-花旗集团-平安好医生（1833）_平安好医生（1833.HK）_更名为平安好医生-人工智能集成家庭医生服务_12页_341kb

Final Answer

Ping AN Healthcare and Technology (1833.HK) has rebranded to focus on AI-integrated healthcare services under the "Ping An Good Doctor" initiative, aiming to enhance user experience and implement F2C and B2C strategies. Citigroup Research assigns a Buy/High Risk rating, citing leadership in the internet healthcare sector, growing user base, and unique AI capabilities. Key developments include the launch of "Dr. An," an AI family doctor that provides accurate report interpretation, disease diagnosis, and health consultations, improving medical efficiency by ~62% in 2024. The company has developed various AI agents and a "7+N+1" product matrix, leveraging proprietary AI models like Ping An Medical Master. Financially, earnings are expected to grow, with a target price of HK$12 based on NPV analysis, though risks include short trading history and potential policy or competitive pressures.